Clinical Trials Browser

Interventional × Composite Lymphoma × Rituximab × Clear all

NCT05025800 2025-10-09

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Phase 1/2 Active not recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Composite Lymphoma

NCT02541565 2020-10-14

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma

Phase 1 Completed

30 enrolled 9 charts

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Composite Lymphoma